Humacyte, Inc. (HUMA)
Largest Insider Buys in Sector
HUMA Stock Price History Chart
HUMA Stock Performance
About Humacyte, Inc.
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs). Its investigational HAVs are designed to be easily implanted into any patient without inducing a foreign body response or leading to immune rejection. The company is developing a …
Insider Activity of Humacyte, Inc.
Over the last 12 months, insiders at Humacyte, Inc. have bought $849,373 and sold $55.95M worth of Humacyte, Inc. stock.
On average, over the past 5 years, insiders at Humacyte, Inc. have bought $11.82M and sold $52.77M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Binder Gordon M (director) — $667,500. Wallace Max N. (director) — $50,030. Dougan Brady W (director) — $46,084.
The last purchase of 4,600 shares for transaction amount of $20,181 was made by Constantino Michael T. (director) on 2024‑12‑04.
List of Insider Buy and Sell Transactions, Humacyte, Inc.
| 2024-12-04 | director | 4,600 0.0036% | $4.39 | $20,181 | -3.72% | |||
| 2024-11-20 | Sale | President, CEO and Director | 261,369 0.2032% | $4.40 | $1.15M | -0.68% | ||
| 2024-11-20 | Sale | director | 261,369 0.2032% | $4.40 | $1.15M | -0.68% | ||
| 2024-11-19 | Sale | President, CEO and Director | 427,459 0.3354% | $4.34 | $1.86M | 0.00% | ||
| 2024-11-19 | Sale | director | 427,459 0.3354% | $4.34 | $1.86M | 0.00% | ||
| 2024-11-19 | President, CEO and Director | 1,797 0.0014% | $4.44 | $7,979 | 0.00% | |||
| 2024-11-19 | director | 1,797 0.0014% | $4.44 | $7,979 | 0.00% | |||
| 2024-11-18 | Sale | President, CEO and Director | 811,172 0.6438% | $4.44 | $3.6M | 0.00% | ||
| 2024-11-18 | Sale | director | 811,172 0.6438% | $4.44 | $3.6M | 0.00% | ||
| 2024-09-10 | Sale | President, CEO and Director | 288,674 0.2409% | $5.23 | $1.51M | -0.38% | ||
| 2024-09-10 | Sale | director | 288,674 0.2409% | $5.23 | $1.51M | -0.38% | ||
| 2024-09-10 | Sale | director | 5,182 0.0045% | $5.40 | $28,004 | -0.38% | ||
| 2024-09-09 | Sale | President, CEO and Director | 157,704 0.1329% | $5.42 | $854,756 | -2.78% | ||
| 2024-09-09 | Sale | director | 157,704 0.1329% | $5.42 | $854,756 | -2.78% | ||
| 2024-08-29 | Sale | President, CEO and Director | 352,112 0.3046% | $6.35 | $2.24M | -14.23% | ||
| 2024-08-29 | Sale | director | 352,112 0.3046% | $6.35 | $2.24M | -14.23% | ||
| 2024-08-29 | President, CEO and Director | 1,222 0.0011% | $6.54 | $7,998 | -14.23% | |||
| 2024-08-29 | director | 1,222 0.0011% | $6.54 | $7,998 | -14.23% | |||
| 2024-08-28 | Sale | President, CEO and Director | 277,090 0.2329% | $6.47 | $1.79M | -18.14% | ||
| 2024-08-28 | Sale | director | 277,090 0.2329% | $6.47 | $1.79M | -18.14% |
Insider Historical Profitability
| Dougan Brady W | director | 1730884 1.3452% | $4.69 | 7 | 24 | <0.0001% |
| Niklason Laura E | President, CEO and Director | 1730884 1.3452% | $4.69 | 7 | 24 | <0.0001% |
| Binder Gordon M | director | 160000 0.1244% | $4.69 | 3 | 0 | <0.0001% |
| Constantino Michael T. | director | 16950 0.0132% | $4.69 | 4 | 0 | <0.0001% |
| Wallace Max N. | director | 4015 0.0031% | $4.69 | 1 | 0 |
Institutional Investor Ownership
| BlackRock | $14.89M | 4.02 | 4.79M | -2.26% | -$343,807.43 | <0.0001 | |
| The Vanguard Group | $12.5M | 3.38 | 4.02M | +28.7% | +$2.79M | <0.0001 | |
| Aigh Capital Management Llc | $6.71M | 1.81 | 2.16M | New | +$6.71M | 3.83 | |
| Sio Capital Management LLC | $6.22M | 1.68 | 2M | New | +$6.22M | 2.24 | |
| Geode Capital Management | $4.2M | 1.13 | 1.35M | +1.88% | +$77,333.08 | <0.0001 |